Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, EXEL, RSP, UNH, NTRA, and represent 27.76% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ADSK (+$544M), MCK (+$348M), IBIT (+$309M), TMO (+$273M), SCHW (+$235M), IBB (+$212M), LNTH (+$211M), HIMS (+$202M), UNH (+$184M), BMY (+$180M).
- Started 22 new stock positions in Aleanna, TNGX, EW, WGS, JANX, SLNO, ARWR, BMY, GEHC, ADSK. MCK, SRRK, WAY, MARA, GXO, Cara Therapeutics, ASHR, TYRA, Beyond Meat, Aleanna, CAPR, SCHW.
- Reduced shares in these 10 stocks: SPY (-$633M), Catalent (-$508M), CRM (-$279M), , SPGI (-$246M), IWM (-$221M), SHW (-$212M), SRCL (-$192M), Southwestern Energy Company (-$185M), DIS (-$156M).
- Sold out of its positions in AMGN, AMLX, ANAB, ASND, RNA, AXNX, BYND, CARA, Catalent, CNC.
- Farallon Capital Management was a net seller of stock by $-1.3B.
- Farallon Capital Management has $20B in assets under management (AUM), dropping by -6.02%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 137 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 12.6 | $2.5B | -20% | 4.2M | 586.08 |
|
| Exelixis (EXEL) | 4.0 | $781M | -7% | 23M | 33.30 |
|
| Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP) | 3.9 | $771M | 4.4M | 175.23 |
|
|
| UnitedHealth (UNH) | 3.8 | $740M | +33% | 1.5M | 505.86 |
|
| Natera (NTRA) | 3.6 | $702M | -2% | 4.4M | 158.30 |
|
| Microsoft Corporation (MSFT) | 3.5 | $688M | +11% | 1.6M | 421.50 |
|
| Aon Shs Cl A (AON) | 3.3 | $658M | +7% | 1.8M | 359.16 |
|
| Thermo Fisher Scientific (TMO) | 3.3 | $642M | +73% | 1.2M | 520.23 |
|
| Iqvia Holdings (IQV) | 3.1 | $614M | 3.1M | 196.51 |
|
|
| Revolution Medicines (RVMD) | 2.9 | $580M | +17% | 13M | 43.74 |
|
| Autodesk (ADSK) | 2.8 | $544M | NEW | 1.8M | 295.57 |
|
| Transunion (TRU) | 2.5 | $494M | -2% | 5.3M | 92.71 |
|
| Walt Disney Company (DIS) | 2.5 | $493M | -24% | 4.4M | 111.35 |
|
| Ishares Tr Ishares Biotech Put Option (IBB) | 2.4 | $476M | +80% | 3.6M | 132.21 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.4 | $476M | +79% | 5.3M | 89.46 |
|
| Intuit (INTU) | 2.4 | $474M | +19% | 754k | 628.50 |
|
| Boston Scientific Corporation (BSX) | 2.3 | $449M | -7% | 5.0M | 89.32 |
|
| Aramark Hldgs (ARMK) | 2.2 | $426M | 11M | 37.31 |
|
|
| salesforce (CRM) | 2.1 | $405M | -40% | 1.2M | 334.33 |
|
| Alphabet Cap Stk Cl C (GOOG) | 2.0 | $396M | -13% | 2.1M | 190.44 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 2.0 | $385M | +404% | 7.3M | 53.05 |
|
| New York Times Cl A (NYT) | 1.9 | $384M | -15% | 7.4M | 52.05 |
|
| Sarepta Therapeutics (SRPT) | 1.8 | $348M | +11% | 2.9M | 121.59 |
|
| McKesson Corporation (MCK) | 1.8 | $348M | NEW | 611k | 569.91 |
|
| Airbnb Com Cl A (ABNB) | 1.6 | $319M | +2% | 2.4M | 131.41 |
|
| Nasdaq Omx (NDAQ) | 1.6 | $309M | +6% | 4.0M | 77.31 |
|
| Cbre Group Cl A (CBRE) | 1.5 | $286M | -26% | 2.2M | 131.29 |
|
| Wabtec Corporation (WAB) | 1.4 | $271M | -35% | 1.4M | 189.59 |
|
| Woodward Governor Company (WWD) | 1.3 | $253M | +31% | 1.5M | 166.42 |
|
| Analog Devices (ADI) | 1.2 | $246M | -21% | 1.2M | 212.46 |
|
| Charles Schwab Corporation (SCHW) | 1.2 | $235M | NEW | 3.2M | 74.01 |
|
| Protagonist Therapeutics (PTGX) | 1.2 | $229M | 5.9M | 38.60 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $208M | +250% | 4.1M | 51.13 |
|
| Beam Therapeutics (BEAM) | 1.0 | $204M | 8.2M | 24.80 |
|
|
| Hims & Hers Health Com Cl A (HIMS) | 1.0 | $203M | +64338% | 8.4M | 24.18 |
|
| Agios Pharmaceuticals (AGIO) | 0.9 | $187M | 5.7M | 32.86 |
|
|
| Bristol Myers Squibb (BMY) | 0.9 | $180M | NEW | 3.2M | 56.56 |
|
| Full Truck Alliance Sponsored Ads (YMM) | 0.9 | $180M | -19% | 17M | 10.82 |
|
| Visa Com Cl A (V) | 0.9 | $174M | -26% | 550k | 316.04 |
|
| Biohaven (BHVN) | 0.8 | $165M | +21% | 4.4M | 37.35 |
|
| Mastercard Incorporated Cl A (MA) | 0.8 | $156M | -41% | 296k | 526.57 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.8 | $151M | -6% | 2.4M | 64.18 |
|
| Bridgebio Pharma (BBIO) | 0.6 | $115M | +140% | 4.2M | 27.44 |
|
| Moderna Put Option (MRNA) | 0.6 | $109M | -25% | 2.6M | 41.58 |
|
| Masimo Corporation (MASI) | 0.3 | $66M | -68% | 397k | 165.30 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $59M | +24% | 3.5M | 16.75 |
|
| Healthcare Rlty Tr Cl A Com (HR) | 0.3 | $55M | +25% | 3.3M | 16.95 |
|
| Zto Express Cayman Note 1.500% 9/0 (Principal) | 0.3 | $55M | -26% | 55M | 0.99 |
|
| Waystar Holding Corp (WAY) | 0.2 | $49M | NEW | 1.3M | 36.70 |
|
| Encompass Health Corp (EHC) | 0.2 | $43M | +15266% | 461k | 92.35 |
|
| Liquidia Corporation Com New (LQDA) | 0.2 | $39M | 3.3M | 11.76 |
|
|
| GDS HLDGS Sponsored Ads (GDS) | 0.2 | $36M | 1.5M | 23.76 |
|
|
| Tectonic Therapeutic (TECX) | 0.2 | $33M | +37% | 713k | 46.17 |
|
| Capricor Therapeutics Com New (CAPR) | 0.2 | $31M | NEW | 2.3M | 13.80 |
|
| Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR) | 0.1 | $27M | NEW | 1.0M | 26.47 |
|
| Flutter Entmt SHS (FLUT) | 0.1 | $23M | +69% | 90k | 258.45 |
|
| Silicon Motion Technology Sponsored Adr (SIMO) | 0.1 | $22M | -19% | 415k | 54.05 |
|
| Gxo Logistics Incorporated Common Stock (GXO) | 0.1 | $22M | NEW | 513k | 43.50 |
|
| Savara (SVRA) | 0.1 | $21M | +49% | 6.8M | 3.07 |
|
| Zymeworks Del (ZYME) | 0.1 | $20M | -2% | 1.3M | 14.64 |
|
| Latam Airlines Group Sa Sponsored Adr (LTM) | 0.1 | $17M | +105% | 619k | 27.58 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.1 | $15M | NEW | 195k | 76.86 |
|
| Voyager Therapeutics (VYGR) | 0.1 | $15M | +12% | 2.6M | 5.67 |
|
| Tyra Biosciences (TYRA) | 0.1 | $14M | NEW | 1.0M | 13.90 |
|
| Tango Therapeutics (TNGX) | 0.1 | $12M | NEW | 4.0M | 3.09 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $12M | 2.1M | 5.75 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $12M | NEW | 629k | 18.80 |
|
| Nuvalent Inc-a (NUVL) | 0.1 | $12M | 150k | 78.28 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.0 | $9.7M | NEW | 124k | 78.18 |
|
| Marathon Digital Holdings In (MARA) | 0.0 | $9.3M | NEW | 555k | 16.77 |
|
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.0 | $6.3M | 600k | 10.50 |
|
|
| Biodesix (BDSX) | 0.0 | $5.8M | -17% | 3.8M | 1.53 |
|
| Dyne Therapeutics (DYN) | 0.0 | $5.4M | -46% | 229k | 23.56 |
|
| Soleno Therapeutics (SLNO) | 0.0 | $4.0M | NEW | 90k | 44.95 |
|
| Grindr *w Exp 11/18/202 (GRND.WS) | 0.0 | $3.6M | 540k | 6.75 |
|
|
| Mac Copper Ord Shs (MTAL) | 0.0 | $3.5M | -19% | 331k | 10.62 |
|
| Vnet Group Sponsored Ads A (VNET) | 0.0 | $3.1M | 650k | 4.74 |
|
|
| Alvotech Ordinary Shares (ALVO) | 0.0 | $2.6M | 200k | 13.23 |
|
|
| Janux Therapeutics (JANX) | 0.0 | $2.6M | NEW | 48k | 53.54 |
|
| Summit Midstream Corporation (SMC) | 0.0 | $2.2M | 58k | 37.78 |
|
|
| Prime Medicine (PRME) | 0.0 | $2.2M | 750k | 2.92 |
|
|
| Elevation Oncology (ELEV) | 0.0 | $2.0M | 3.5M | 0.56 |
|
|
| Marblegate Acquisition Corp Com Cl A (GATE) | 0.0 | $1.6M | 150k | 10.99 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $1.0M | 3.3k | 308.57 |
|
|
| Forte Biosciences Com New (FBRX) | 0.0 | $795k | -51% | 35k | 22.71 |
|
| Cara Therapeutics Com New | 0.0 | $794k | NEW | 130k | 6.12 |
|
| Roivant Sciences SHS (ROIV) | 0.0 | $438k | 37k | 11.83 |
|
|
| Glaukos (GKOS) | 0.0 | $390k | 2.6k | 149.94 |
|
|
| Brightspring Health Svcs (BTSG) | 0.0 | $375k | 22k | 17.03 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $362k | 26k | 13.93 |
|
|
| Twist Bioscience Corp (TWST) | 0.0 | $356k | -97% | 7.7k | 46.47 |
|
| United Therapeutics Corporation (UTHR) | 0.0 | $353k | 1.0k | 352.84 |
|
|
| Blueprint Medicines (BPMC) | 0.0 | $349k | 4.0k | 87.22 |
|
|
| Axsome Therapeutics (AXSM) | 0.0 | $338k | 4.0k | 84.61 |
|
|
| Krystal Biotech (KRYS) | 0.0 | $313k | 2.0k | 156.66 |
|
|
| Progyny (PGNY) | 0.0 | $311k | -98% | 18k | 17.25 |
|
| Arcellx Common Stock (ACLX) | 0.0 | $307k | 4.0k | 76.69 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $303k | NEW | 7.0k | 43.22 |
|
| Hca Holdings (HCA) | 0.0 | $300k | 1.0k | 300.15 |
|
|
| Globus Med Cl A (GMED) | 0.0 | $298k | 3.6k | 82.71 |
|
|
| Immunovant (IMVT) | 0.0 | $297k | 12k | 24.77 |
|
|
| Bruker Corporation (BRKR) | 0.0 | $293k | -84% | 5.0k | 58.62 |
|
| Merit Medical Systems (MMSI) | 0.0 | $290k | 3.0k | 96.72 |
|
|
| Healthequity (HQY) | 0.0 | $269k | 2.8k | 95.95 |
|
|
| Pacific Biosciences of California (PACB) | 0.0 | $247k | 135k | 1.83 |
|
|
| Sabra Health Care REIT (SBRA) | 0.0 | $243k | 14k | 17.32 |
|
|
| Sage Therapeutics (SAGE) | 0.0 | $232k | 43k | 5.43 |
|
|
| AmerisourceBergen (COR) | 0.0 | $225k | -99% | 1.0k | 224.68 |
|
| Edwards Lifesciences (EW) | 0.0 | $222k | NEW | 3.0k | 74.03 |
|
| ICU Medical, Incorporated (ICUI) | 0.0 | $217k | 1.4k | 155.17 |
|
|
| Chemed Corp Com Stk (CHE) | 0.0 | $212k | 400.00 | 529.80 |
|
|
| Icon SHS (ICLR) | 0.0 | $210k | -99% | 1.0k | 209.71 |
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $208k | 28k | 7.44 |
|
|
| Insmed Com Par $.01 (INSM) | 0.0 | $207k | 3.0k | 69.04 |
|
|
| Beigene Sponsored Adr | 0.0 | $203k | 1.1k | 184.71 |
|
|
| Altimmune Com New (ALT) | 0.0 | $199k | 28k | 7.21 |
|
|
| Elanco Animal Health (ELAN) | 0.0 | $194k | 16k | 12.11 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $192k | 26k | 7.40 |
|
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $182k | 405k | 0.45 |
|
|
| Evolent Health Cl A (EVH) | 0.0 | $158k | -97% | 14k | 11.25 |
|
| Geron Corporation (GERN) | 0.0 | $152k | 43k | 3.54 |
|
|
| Amicus Therapeutics (FOLD) | 0.0 | $151k | 16k | 9.42 |
|
|
| Oscar Health Cl A (OSCR) | 0.0 | $148k | 11k | 13.44 |
|
|
| Aleanna *w Exp 12/13/202 | 0.0 | $139k | NEW | 990k | 0.14 |
|
| Cogent Biosciences (COGT) | 0.0 | $133k | 17k | 7.80 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $132k | 10k | 13.22 |
|
|
| Novavax Com New (NVAX) | 0.0 | $129k | 16k | 8.04 |
|
|
| Ardelyx (ARDX) | 0.0 | $117k | 23k | 5.07 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $101k | 28k | 3.60 |
|
|
| Canopy Growth Corp Com New (CGC) | 0.0 | $82k | 30k | 2.74 |
|
|
| Beyond Meat | 0.0 | $71k | NEW | 19k | 3.76 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $58k | 13k | 4.43 |
|
|
| Aleanna Com Cl A | 0.0 | $49k | NEW | 78k | 0.62 |
|
| Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW) | 0.0 | $48k | 1.5M | 0.03 |
|
|
| Cartica Acquisition Corp *w Exp 04/30/202 (CITEW) | 0.0 | $47k | 175k | 0.27 |
|
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $25k | 375k | 0.07 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $19k | 120k | 0.16 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2024 Q1 amended filed Feb. 14, 2025
- Farallon Capital Management 2024 Q2 amended filed Feb. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Feb. 14, 2025
- Farallon Capital Management 2024 Q4 filed Feb. 14, 2025
- Farallon Capital Management 2024 Q3 filed Nov. 14, 2024
- Farallon Capital Management 2024 Q2 amended filed Nov. 14, 2024
- Farallon Capital Management 2024 Q2 filed Aug. 14, 2024
- Farallon Capital Management 2024 Q1 amended filed Aug. 14, 2024
- Farallon Capital Management 2024 Q1 restated filed May 24, 2024
- Farallon Capital Management 2024 Q1 filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed May 15, 2024
- Farallon Capital Management 2023 Q4 amended filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed Feb. 12, 2024
- Farallon Capital Management 2023 Q3 filed Nov. 14, 2023
- Farallon Capital Management 2022 Q1 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q2 amended filed Nov. 14, 2023